AFYREN achieves “Responsible Care® Confirmed Diagnosis” certification and publishes its second sustainability report
Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor
Smart tools for smart investors can be found in our Tools section
Corporate News Afyren SAS
AFYREN achieves “Responsible Care® Confirmed Diagnosis” certification and publishes its second sustainability report
AFYREN and Südzucker celebrate 5 years of strategic bioeconomy partnership
AFYREN strengthens its Executive Committee with appointment of Laurent Pou as Industrial Director
AFYREN announces its 2024 full-year financial results
AFYREN provides business update and announces a €10 million sustainable financing for its subsidiary AFYREN NEOXY
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Corporate Research | 0 | - | - | Corporate Research |
| Directors Dealings | 0 | - | - | DD |
| Short Seller (DE) | 0 | - | - | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.